Malin Corporation plc
Malin Corporation plc, through its subsidiaries, operates in the life sciences industry in Ireland and the United States. It also engages in investment activities. The company was incorporated in 2014 and is headquartered in Dublin, Ireland.
Malin Corporation plc (MLC) - Net Assets
Latest net assets as of December 2024: €193.20 Million EUR
Based on the latest financial reports, Malin Corporation plc (MLC) has net assets worth €193.20 Million EUR as of December 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€198.50 Million) and total liabilities (€5.30 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €193.20 Million |
| % of Total Assets | 97.33% |
| Annual Growth Rate | -6.83% |
| 5-Year Change | -33.4% |
| 10-Year Change | N/A |
| Growth Volatility | 42.76 |
Malin Corporation plc - Net Assets Trend (2015–2024)
This chart illustrates how Malin Corporation plc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Malin Corporation plc (2015–2024)
The table below shows the annual net assets of Malin Corporation plc from 2015 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €193.20 Million | +76.44% |
| 2023-12-31 | €109.50 Million | -61.32% |
| 2022-12-31 | €283.10 Million | +29.33% |
| 2021-12-31 | €218.90 Million | -24.54% |
| 2020-12-31 | €290.10 Million | +61.98% |
| 2019-12-31 | €179.10 Million | +5.11% |
| 2018-12-31 | €170.40 Million | -23.04% |
| 2017-12-31 | €221.40 Million | -28.14% |
| 2016-12-31 | €308.10 Million | -15.68% |
| 2015-12-31 | €365.40 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Malin Corporation plc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 29260000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €247.70 Million | 128.21% |
| Total Equity | €193.20 Million | 100.00% |
Malin Corporation plc Competitors by Market Cap
The table below lists competitors of Malin Corporation plc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
PHN
F:2PN
|
$30.54 Million |
|
Very Good Tour Co. Ltd
KQ:094850
|
$30.55 Million |
|
Para Light Electronics Co Ltd
TW:6226
|
$30.55 Million |
|
TY Holdings Co Ltd
KO:363280
|
$30.56 Million |
|
Chung Fu Tex-International Corp
TW:1435
|
$30.53 Million |
|
ESTec Corporation
KQ:069510
|
$30.52 Million |
|
Ribbon Acquisition Corp Class A Ordinary Shares
NASDAQ:RIBB
|
$30.51 Million |
|
TTK Healthcare Limited
NSE:TTKHLTCARE
|
$30.49 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Malin Corporation plc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 109,500,000 to 193,200,000, a change of 83,700,000 (76.4%).
- Other factors increased equity by 83,700,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €0.00 | -0.0% |
| Other Changes | €83.70 Million | +43.32% |
| Total Change | €- | 76.44% |
Book Value vs Market Value Analysis
This analysis compares Malin Corporation plc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.75x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.60x to 0.75x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2015-12-31 | €12.71 | €7.60 | x |
| 2016-12-31 | €7.26 | €7.60 | x |
| 2017-12-31 | €4.96 | €7.60 | x |
| 2018-12-31 | €3.51 | €7.60 | x |
| 2019-12-31 | €3.68 | €7.60 | x |
| 2020-12-31 | €6.04 | €7.60 | x |
| 2021-12-31 | €4.77 | €7.60 | x |
| 2022-12-31 | €8.21 | €7.60 | x |
| 2023-12-31 | €5.77 | €7.60 | x |
| 2024-12-31 | €10.18 | €7.60 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Malin Corporation plc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.03x
- Recent ROE (0.00%) is above the historical average (-6.86%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | -12.85% | -196.07% | 0.05x | 1.21x | €-79.83 Million |
| 2016 | -29.20% | -198.34% | 0.10x | 1.41x | €-112.10 Million |
| 2017 | -47.66% | -235.80% | 0.14x | 1.49x | €-119.53 Million |
| 2018 | -28.85% | -121.84% | 0.14x | 1.65x | €-62.35 Million |
| 2019 | -3.20% | -15.47% | 0.13x | 1.61x | €-22.29 Million |
| 2020 | 31.34% | 213.90% | 0.11x | 1.32x | €59.72 Million |
| 2021 | 17.27% | 0.00% | 0.00x | 1.04x | €15.91 Million |
| 2022 | 4.56% | 0.00% | 0.00x | 1.02x | €-15.41 Million |
| 2023 | 0.00% | 0.00% | 0.00x | 1.06x | €-10.95 Million |
| 2024 | 0.00% | 0.00% | 0.00x | 1.03x | €-19.32 Million |
Industry Comparison
This section compares Malin Corporation plc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
No peer company data available for comparison.